Problem

Specialty pharmacies often receive prescriptions for home infusions but lack a fast, reliable way to staff the nurse visit. The pain is operational and economic: pharmacies may rely on paper systems, outdated EMRs, physical Rolodexes, and sticky notes to manage referrals, nurse availability, rescheduling, and documentation. When a nurse cannot be sourced, a prescription may go unfilled or a patient may need treatment in an overcrowded hospital instead of at home. The central use case is therefore helping a specialty pharmacy turn an inbound infusion prescription into a completed, properly documented home visit.

The economics are meaningful for all sides. Float says its marketplace costs 23–25% less than in-house nursing, while home infusion can reduce healthcare costs, improve patients’ quality of life, and open hospital capacity. For nurses, the alternative to long hospital shifts is flexible, shorter home visits that Float says pay 1.5–2 times hospital rates.

Product / Service

Float Health is an on-demand home-infusion nursing marketplace and specialty-pharmacy workflow platform. A pharmacy sends a patient referral to Float; Float uses its network and AI-powered platform to source a qualified local infusion nurse, coordinate the visit, and support charting and reimbursement. Nurses are notified of available home visits and choose the assignments that fit their schedules. The service is designed for clinical work such as IV starts, port access, and administration of biologics, biosimilars, chemotherapy, and routine medications.

The platform extends beyond matching. Float provides scheduling, nurse vetting, mobile EMR charting, compliance support, invoicing, and documentation from referral through reimbursement. Its stated benefit is faster fulfillment—minutes rather than days or weeks—along with better visibility for pharmacies, less administrative friction, lower staffing costs, and care that keeps patients out of hospitals.

Market

Float competes in healthtech at the intersection of specialty-pharmacy infrastructure, healthcare staffing marketplaces, and alternate-site or home-infusion services. Its most direct alternatives are traditional in-house nursing, legacy nursing sources, manual pharmacy workflows, and established home-infusion providers. Market overviews name providers such as Option Care Health, Coram, Medix Infusion, and CVS Health among broader home-infusion competitors, although Option Care and CVS are also listed as Float customers, suggesting that some large providers may be customers, partners, or competitors depending on the service layer.

The evidence indicates that Float is commercially active rather than pre-revenue, although the sources do not disclose revenue. Float reports customers including Optum, CVS, Option Care, AllianceRx Walgreens, Kroger, KabaFusion, Soleo Health, NuFactor, Care Fusion, and CA Specialty Pharmacy; it also reports a 98–100% weekly staffing rate and staffing in minutes instead of days to weeks. The company was founded in 2021, joined Y Combinator’s Winter 2022 batch, and announced a $10 million Series A in March 2024, bringing total funding to $15 million. Its cited operating footprint included California, Arizona, Texas, Washington, and Nevada, with additional markets expanding.